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Abstract
Background: Independent of efficacy, information on safety of surgical procedures is essential for informed choices.
We seek to develop standardized methodology for describing the safety of spinal operations and apply these methods
to study lumbar surgery. We present a conceptual model for evaluating the safety of spine surgery and describe
development of tools to measure principal components of this model: (1) specifying outcome by explicit criteria for
adverse event definition, mode of ascertainment, cause, severity, or preventability, and (2) quantitatively measuring
predictors such as patient factors, comorbidity, severity of degenerative spine disease, and invasiveness of spine surgery.
Methods: We created operational definitions for 176 adverse occurrences and established multiple mechanisms for
reporting them. We developed new methods to quantify the severity of adverse occurrences, degeneration of lumbar
spine, and invasiveness of spinal procedures. Using kappa statistics and intra-class correlation coefficients, we assessed
agreement for the following: four reviewers independently coding etiology, preventability, and severity for 141 adverse
occurrences, two observers coding lumbar spine degenerative changes in 10 selected cases, and two researchers coding
invasiveness of surgery for 50 initial cases.
Results: During the first six months of prospective surveillance, rigorous daily medical record reviews identified 92.6%
of the adverse occurrences we recorded, and voluntary reports by providers identified 38.5% (surgeons reported 18.3%,
inpatient rounding team reported 23.1%, and conferences discussed 6.1%). Trained observers had fair agreement in
classifying etiology of 141 adverse occurrences into 18 categories (kappa = 0.35), but agreement was substantial (kappa
≥ 0.61) for 4 specific categories: technical error, failure in communication, systems failure, and no error. Preventability
assessment had moderate agreement (mean weighted kappa = 0.44). Adverse occurrence severity rating had fair
agreement (mean weighted kappa = 0.33) when using a scale based on the JCAHO Sentinel Event Policy, but agreement
was substantial for severity ratings on a new 11-point numerical severity scale (ICC = 0.74). There was excellent inter-
rater agreement for a lumbar degenerative disease severity score (ICC = 0.98) and an index of surgery invasiveness (ICC
= 0.99).
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Conclusion: Composite measures of disease severity and surgery invasiveness may allow development of risk-adjusted
predictive models for adverse events in spine surgery. Standard measures of adverse events and risk adjustment may also
facilitate post-marketing surveillance of spinal devices, effectiveness research, and quality improvement.
Background
An early warning system is needed to identify surgical
devices and techniques that perform poorly when intro-
duced into general practice [1]. Expensive technological
innovations commonly gain widespread use based on
limited comparative data and minimal systematic post-
marketing surveillance [2]. Thus, awareness of adverse
effects associated with these innovations accumulates
haphazardly and disseminates slowly [3].
Adverse event assessment in spine surgery is mired by
additional difficulties. In contrast to certain other proce-
dures (such as hip and knee arthroplasty) that are fairly
standardized across patients, spine surgery is much more
individualized for the specific spinal pathology, combin-
ing various graft materials and fixation devices with vary-
ing degrees of vertebral decompression and fusion.
Randomized trials of spine surgery typically focus on one
or a few specific types of procedures, providing limited
comparative data on the safety of different surgical
approaches and devices. In observational studies, which
in many ways are better suited for safety assessment [4,5],
procedural variations might obscure the impact of a spe-
cific treatment. Also, the effects of treatment may differ
across different groups of patients. This study was
designed to develop measures and an analytical model to
adjust for these variations when assessing safety of spine
surgery.
We propose studying the safety of spine surgery for degen-
erative disease through a conceptual model in which
safety is broadly defined as a function of preoperative
patient, disease, and treatment characteristics:
Therapeutic Safety =  f{Patient Characteristics|Disease
Attributes|Treatment Factors}
In this framework, the effect of an individual treatment
factor on safety can potentially be distinguished from the
effects of other relevant patient and disease characteristics
(Figure 1).
Specification of therapeutic safety is central to this model.
Safety may be specified as a narrowly defined particular
outcome, or it may be described as a set of adverse events
characterized by specific criteria for timing, setting, sever-
ity, preventability, or causal pathway. Consistent termi-
nology and definitions for safety outcomes are essential,
both for comparing treatments and for assessing improve-
ments over time [6].
Patient characteristics relevant for predicting surgical
adverse events include age [7], height and weight (body
mass index) [8], smoking status [9], burden of coexisting
medical conditions [10], gender, and race [11,12]. When
assessing consequences of an adverse event on clinical
outcomes, such as pain or function, adjustment may also
be necessary for psychosocial factors such as education,
work conditions, and psychological stress [13].
To measure the severity of spinal disease, new methods
are needed. Neurological function may be designated sim-
ply as normal or abnormal, or quantified by a score such
as the American Spinal Injury Association (ASIA) motor
score [14]. Prior surgery at the involved spinal segments
may be measured as yes-no or as the number of prior
operations. Quantifying degenerative structural changes
across multiple spinal segments is more challenging, but
at minimum, the methods must account for the severity of
disc space and facet joint degeneration [15], spinal steno-
sis [16,17], and vertebral mal-alignment such as spondy-
lolisthesis [12], scoliosis [18], and kyphosis [19].
New methods are also needed to measure treatment (sur-
gical procedure) factors. Differences in the "invasiveness"
of surgical procedures (e.g., route of surgical access, loca-
tion of nerve roots decompressed, number of vertebrae
fused and instrumented) influence risks.
The following multivariate analytical model provides a
more detailed specification of the conceptual framework
for evaluating the safety of spine surgery for degenerative
disease:
Multiple regression methods such as logistic regression
can estimate independent effects of each variable on the
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We are evaluating the feasibility and utility of this concep-
tual model for measuring the safety of different types of
lumbar spine surgery. The initial goals of this project are:
(1) to identify the frequency, nature, and severity of
adverse occurrences associated with lumbar spine surgery;
(2) to quantify the severity of lumbar degenerative
changes;
(3) to quantify the invasiveness of the surgical procedure.
Longer term goals are:
(4) to measure the consequences of adverse events on
pain and patient-reported health status two years after sur-
gery; and
(5) to combine these new measures of disease severity and
surgical invasiveness with established medical co-morbid-
ity measures in predictive models of adverse events.
In this report, using data from the initial six months of the
study, we describe the methods and the preliminary
results for the first three goals.
Methods
Definitions
We define an adverse occurrence as any medical event in
the course of a patient's treatment that has the potential
for causing harm to the patient. We selected the term
"adverse occurrence" to avoid the connotation of blame
often associated with the term "complication." We reserve
the term "adverse event" for the subset of adverse occur-
rences where the patient experiences harm or requires
additional monitoring or intervention [20].
Study design
This report describes research conducted to develop ana-
lytical tools for a prospective cohort study of adverse
occurrences in lumbar spine surgery. The inclusion and
exclusion criteria for the lumbar study are listed in Table
1. The University of Washington (UW) institutional
review board approved the study. For this report, we relied
on data collected during first six months of that study.
Outcomes
The primary outcome is a discrete variable that indicates
the presence of an adverse occurrence (1 = yes, 0 = no). In
the future, we will measure the sensitivity of the safety
assessment to different thresholds of adverse occurrence
Framework for Safety Assessment Figure 1
Framework for Safety Assessment. The relationship of patient, disease, and treatment factors to adverse outcomes.BMC Musculoskeletal Disorders 2006, 7:53 http://www.biomedcentral.com/1471-2474/7/53
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type, etiology, severity, and preventability. In addition to
evaluating the association of adverse occurrences with
patient, disease, and treatment factors, we will also exam-
ine their effect on hospital stay duration, re-admission, re-
operation, and patient-reported health status at two years
following surgery. We hypothesize that some complica-
tions that appear to resolve with treatment post-opera-
tively (e.g., wound infection, cerebrospinal fluid leak)
may have lasting effects on pain and function. We are
measuring back and leg pain using numerical ratings of
intensity and bothersomeness [21-23] and health status
by the Short Form-36 [24-26]. We are also measuring pain
medication use, work status, and patient satisfaction.
Ascertaining adverse occurrences
We created a priori definitions and ascertainment criteria
for 176 adverse occurrences. One orthopedic surgeon and
two neurosurgeons specializing in spinal surgery reviewed
a list of spine surgery complications [27], eliminated
redundancy, and developed explicit definitions for 70
adverse occurrences. Two hospitalists with experience
studying surgical complications provided operational def-
initions for 56 other adverse occurrences [28]. Anesthesi-
ologists experienced in studying anesthetic adverse
occurrences provided definitions for 30 peri-operative
anesthetic events [29]. With input from operating room
nurses, technicians, and managers, we developed criteria
for 20 adverse process-of-surgical care issues (e.g., lack of
appropriate equipment, implants, documentation, or
diagnostic studies). The final list of adverse occurrences
and their definitions are provided in the Appendix [see
Additional file 1]. 
In addition to prospective, daily, rigorous medical record
review by research staff, we established six other mecha-
nisms for surgeons, residents, fellows, and other team
members to independently and voluntarily report adverse
occurrences: (1) confidential forms in the operating
rooms, inpatient areas, and outpatient clinics with
secured collection-boxes; (2) dedicated telephone lines at
each hospital; (3) privacy-protected email; (4) weekly
spine clinical conferences; (5) daily inpatient rounds; and
(6) outpatient clinics [30]. Occurrences from the last three
sources were recorded by a designated nurse or physician
assistant. We tracked all the modes through which each
occurrence was identified.
Categorizing adverse occurrences
Adverse events in spine surgery are often arbitrarily
reported as "device-related," "major," or "preventable."
These judgments are not always straightforward, and they
profoundly influence interpretation of safety data. Com-
parisons are difficult unless the terms are applied consist-
ently. We, therefore, used four reviewers to evaluate the
consistency of assigning etiology, severity, and preventa-
bility to adverse occurrences.
Reviewers were selected from different backgrounds to
allow broad clinical perspective. They included a spine fel-
lowship-trained orthopedic surgeon with 7 years of expe-
rience, a spine fellowship-trained neurosurgeon with
more than 5 years experience, a neurosurgeon with more
than 25 years of experience, and an anesthesiologist with
more than 5 years of experience. Reviewers individually
classified adverse occurrences using pre-established oper-
ational definitions [see Additional file 1] and categoriza-
tion schemes (Tables 2, 3, and 4) and then discussed them
as a group in three one-hour training sessions. Subse-
quently, the four reviewers independently coded adverse
occurrences recorded during the first six months of the
study.
The reviewers were provided a brief narrative describing
each adverse occurrence and the patient's history, surgery,
and other information available at discharge. Reviewers
were asked to confirm that the reported event met the pre-
defined ascertainment criteria and to judge the event's
causes, preventability, and severity. Reviewers selected
Table 1: Inclusion and exclusion criteria.1
Inclusion criteria:
1. Age greater than 18 years (to allow informed consent).
2. Diagnosis is lumbar degenerative disease (disc degeneration, disc herniation, spinal stenosis, spondylolisthesis, or degenerative scoliosis).
3. Surgery involves at least one lumbar vertebra.
4. Surgery at Harborview Medical Center or University of Washington Medical Center.
Exclusion criteria:
1. Inflammatory spondyloarthropathy.
2. Spinal malignancy or infection.
3. Pregnancy.
4. No telephone contact, or planning to move within a year.
5. Unable to complete study questionnaires or follow-up telephone interviews in English.
1Concurrent with the initiation of this study, we established a spine registry to track safety and outcomes of all spine surgery procedures at the 
University of Washington (the Spine End Results Registry). Research coordinators attempt to offer most patients scheduled for spine surgery at the 
University of Washington the opportunity to enroll in the registry, but because of limited staff, only the busiest spine clinics are staffed with 
research coordinators. The criteria listed here specify the subset of registry patients selected for studying lumbar surgery for degenerative disease.BMC Musculoskeletal Disorders 2006, 7:53 http://www.biomedcentral.com/1471-2474/7/53
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contributing etiological factors from a list of 15 types of
errors developed for the Harvard Medical Practice Study
and three additional factors for no error (Table 2) [31,32].
Reviewers could select multiple factors, but identified a
dominant or most important factor. Reviewers coded pre-
ventability as clearly unpreventable, potentially preventa-
ble, or clearly preventable [31,32]. For severity coding, we
provided the reviewers the adverse event severity catego-
rizing scheme based on the Sentinel Event Reporting Pol-
icy required by the Joint Commission on Accreditation of
Healthcare Organizations (JCAHO) (Table 3) [33]. By
design, this scheme does not distinguish quality of care
concerns from patient outcomes, or real effects from
potential effects, requiring institutions to define "sentinel
event" specifically for their own purposes with "latitude in
setting more specific parameters to define 'unexpected,'
'serious,' and 'the risk thereof"' [33]. To measure the
impact of adverse occurrences independent of quality of
care, with separation of potential risk and actual effect, we
developed an "Adverse Occurrence Severity Score" similar
to the Index for Categorizing Medication Errors developed
by the National Coordinating Council for Medication
Error Reporting and Prevention (NCC MERP)(Table 4)
[34]. For each adverse occurrence, each reviewer identified
the most important factor for etiology, rated preventabil-
ity, and provided both a JCAHO severity rating and an
Adverse Occurrence Severity Score.
Measuring medical comorbidity
Risk evaluation is crucial to predicting surgical outcomes,
but the specific methods most appropriate for spine sur-
gery are unclear. We therefore collected medical comor-
bidity information using multiple methods. Patients
completed a medical history questionnaire to allow calcu-
lation of a Charlson comorbidity score [35-37]. We also
reviewed medical records to identify presence of 32 med-
Table 3: Severity rating based on the JCAHO Sentinel Event Policy for adverse events not related to the natural course of the patient's 
illness or underlying condition.
Code Description
0 No quality of care concerns evident.
1 Did not and unlikely to have had an adverse effect.
2 Did not but had the potential to have had an adverse effect.
3 Had an adverse effect but not life threatening.
4 Resulted in loss of major physical function or potentially life threatening.
5 Demonstrated a life threatening situation or resulted in death.
Table 2: Harvard Medical Practice Study categories for classifying etiology of adverse events and medical errors, with three added 
categories for patient factors.
Code Type of Error Description
1 Diagnostic Error in diagnosis or delay in diagnosis
2 Diagnostic Failure to employ an indicated test
3 Diagnostic Use of outmoded tests or therapy
4 Diagnostic Failure to act on the results of monitoring or testing
5 Treatment Technical error in performance of an operation, procedure, or test
6 Treatment Error in administering the treatment (including preparation for operation or treatment)
7 Treatment Error in dose of drug or in the method of use of a drug
8 Treatment Avoidable delay in treatment or in responding to an abnormal test
9 Treatment Inappropriate (not indicated) care. Considering the patient's disease, its severity, and comorbidity, the anticipated benefit 
from the treatment did not significantly exceed the known risk, or a superior alternative was available
10 Preventive Failure to provide indicated prophylactic treatment
11 Preventive' Inadequate monitoring or follow-up of treatment
12 System Failure in communication
13 System Equipment failure
14 System Other systems failure
15 Other Unclassified
*16 No error Patient disease, expected risk
*17 No error Patient non-compliance
*18 No error Patient disease, unrelated to spinal surgery
*Additional three categories not included in the Harvard Medical Practice Study. We group these as "no error" simply to distinguish them from the 
evaluation and treatment associated factors under direct control of the medical care system. Alternatively, these three factors may be considered 
errors in patient selection.BMC Musculoskeletal Disorders 2006, 7:53 http://www.biomedcentral.com/1471-2474/7/53
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ical conditions [38] We additionally recorded the Ameri-
can Society of Anesthesiologists (ASA) grade for anesthetic
risk [39] and each patient's height, weight, and tobacco,
alcohol, and drug use.
Measuring disease severity
Lumbar degeneration (spondylosis) is a broad category
with varying degrees of severity, and surgical procedures
to treat it are individualized to address various aspects of
this condition. Technical difficulty of the surgical proce-
dure, and the associated risk of adverse occurrences, may
be affected by the anatomical changes, such as the severity
of spinal stenosis or the presence and severity of concur-
rent spondylolisthesis and scoliosis. Also, because
patients with more severe and complex spinal disease may
seek out particular providers and hospitals, it is important
to control for disease severity when comparing adverse
occurrences in different settings. We desired a measure of
severity of lumbar degeneration to use in predicting the
probability of an adverse occurrence.
Using literature review and expert opinions, we developed
a severity score using 9 characteristics of degeneration
measurable on imaging studies: (1) intervertebral disc sig-
nal intensity on magnetic resonance (MR) images [40],
(2) intervertebral disc height loss on radiographs or MR
images [41], (3) osteophyte formation on radiographs
[42,43], (4) disc herniation [44], (5) spinal stenosis [45],
(6) spondylolisthesis [46,47], (7) instability on flexion-
extension lateral radiographs [48,49], (8) scoliosis
[50,51], and (9) kyphosis [52]. We developed definitions
for grading severity of each characteristic at each motion
segment (Table 5). We also defined a composite "Degen-
erative Disease Severity Score" as the sum of the scores for
each of the 9 imaging dimensions.
To test the reliability of this disease severity scoring
method, two observers scored 10 imaging studies of
patients showing a broad range of degenerative lumbar
spine changes. Image panels showed lumbar spine ante-
rior-posterior and lateral radiographs, lateral flexion and
extension views, and sagittal views on MR images. To
show the neural tissue space, the panels included an axial
image of the spinal canal, sagittal view of the right
foramen, and sagittal view of the left foramen for each
lumbar level. Each observer rated the 10 cases at two
times, approximately 3 weeks apart, identifying a score for
each case on all 9 imaging dimensions.
Measuring surgery invasiveness
Surgical complexity influences risk of adverse occurrences.
When comparing different surgeons, hospitals, or devices,
the extent and nature of the spinal surgery may be a con-
founding factor. To control for variations in spinal proce-
dures, we developed a quantitative index to rate the
invasiveness of surgery.
We based the index on three fundamental elements of spi-
nal procedures: decompression, fusion, and instrumenta-
tion of individual vertebrae. Combinations of these three
elements on different vertebrae, when combined with sur-
gical approach (anterior or posterior), can be useful in
describing many spinal operations. Each operated verte-
bra can be assigned a score of 0 to 6, based on how many
Table 4: Adverse Occurrence Severity Score developed to distinguish actual effect from the magnitude of risk associated with adverse 
occurrences.
Score Summary Description
0 No effect, no risk Adverse occurrence required no intervention, resulted in no adverse consequences, and had no risk of 
adverse consequences.
1 No effect, minor risk Adverse occurrence required no intervention, resulted in no adverse consequences, but had the potential to 
result in minor consequences.
2 No effect, major risk Adverse occurrence required no intervention, resulted in no adverse consequences, but had the potential to 
result in major but not life threatening adverse consequences.
3 No effect, risk of death Adverse occurrence required no intervention, but had the potential to result in a life-threatening situation or 
death.
4 Minor effect, minor risk Adverse occurrence required a minor intervention or resulted in minor loss of function, and had the potential 
to result in only minor adverse consequences.
5 Minor effect, major risk Adverse occurrence required a minor intervention or resulted in minor loss of function, but had the potential 
to result in major loss of function, though not life-threatening.
6 Minor effect, risk of death Adverse occurrence required a minor intervention or resulted in minor loss of function, but had the potential 
to result in a life-threatening situation or death.
7 Major effect, major risk Adverse occurrence required extensive intervention such as unexpected re-operation or re-admission, or 
resulted in major loss of function, but was not life-threatening.
8 Major effect, risk of death Adverse occurrence required extensive intervention such as unexpected re-operation or re-admission, or 
resulted in major loss of function, and had the potential to result in a life-threatening situation or death.
9 Life-threatening effect Adverse occurrence resulted in a life-threatening situation.
10 Death Adverse occurrence resulted in death.BMC Musculoskeletal Disorders 2006, 7:53 http://www.biomedcentral.com/1471-2474/7/53
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Table 5: Nine subscales for scoring the severity of degenerative changes in the lumbar spine on imaging studies.
1. Degeneration: assign a value 0 to 3 at each level
None 0
Dark disc on T2 MRI 1
End plate edema on T2 MRI 2
End plate sclerosis 3
2. Height loss: assign a value 0 to 3 at each level
None 0
Yes, < 50% 1
Yes, > 50%, but not ankylosis 2
Yes, ankylosis 3
3. Osteophytes: assign a value 0 to 3 at each level
None 0
Yes, < 2 mm 1
Yes, > 2 mm but not bridging 2
Yes, bridging 3






5. Stenosis: assign the total score 0 to 6 for each level
Right foramen 0 or 1 Value for stenosis is the sum of these components or 6 if there is complete block.
Left foramen 0 or 1
Right lateral recess 0 or 1
Left lateral recess 0 or 1
Central stenosis 0 or 1
Complete block 6
6. Listhesis: assign a value 0 to 5 for each level
None, <10% 0
Grade 1, 10 to 25% 1
Grade 2, 26 to 50% 2
Grade 3, 51 to 75% 3
Grade 4, 76 to 100% 4
Grade 5, > 100% 5





8. Scoliosis and 9. Kyphosis: specify total magnitude 0 to 6 for each patient
<10 degrees 0
11 to 19 degrees 1
20 to 29 degrees 2
30 to 39 degrees 3
40 to 49 degrees 4
50 to 59 degrees 5
> 60 degrees 6BMC Musculoskeletal Disorders 2006, 7:53 http://www.biomedcentral.com/1471-2474/7/53
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of six procedural elements were performed at that level:
anterior decompression, anterior fusion, anterior instru-
mentation, posterior decompression, posterior fusion,
and posterior instrumentation.
We scored the six constituent procedure components
using the following definitions:
(1) Anterior decompression: 1 unit for each vertebra
requiring partial or complete excision of the vertebral
body or the disc caudal to that vertebra.
(2) Anterior fusion: 1 unit for each vertebra that has graft
material attached to or replacing that vertebral body.
(3) Anterior instrumentation: 1 unit for each vertebral
body that has screws, plate, cage, or structural graft
attached to its vertebral body or replacing its vertebral
body.
(4) Posterior decompression: 1 unit for each vertebra
requiring laminectomy or foraminotomy at the foramen
caudal to its pedicle and/or discectomy at the disc caudal
to that vertebral body.
(5) Posterior fusion: 1 unit for each vertebra that has graft
material on its lamina, facets, or transverse processes.
(6) Posterior instrumentation: 1 unit for each vertebra
that has screws, hooks, or wires attached to its pedicles,
facets, lamina, or transverse processes.
Each of the six procedure elements can thus be assigned
an integer value corresponding to the number of vertebrae
on which that procedural component was performed. We
also defined a composite "Spine Surgery Invasiveness
Index" as the sum of the six procedural element scores for
a given surgery. We developed a graphical grid for coding
each surgery (Figure 2).
A surgeon-investigator or a trained research assistant com-
pleted the surgical procedure grid based on the treating
surgeon's operative report. To determine if this grid
method could be reliably used in routine clinical docu-
mentation, we made available a medical record form to
allow surgeons to record the spinal procedure using the
grid format in their immediate hand-written brief opera-
tive note. Using the treating surgeon's dictated operation
report as the reference, we assessed the reliability of inva-
siveness coding by comparing the surgeons with the two
researchers for fifty consecutive cases.
Data analysis
We used the kappa statistic to assess agreement between
reviewers, using weighted kappa for ranked scales (pre-
ventability and JCAHO severity scores) [53,54]. We report
kappa values for each pair of observers. Calculations were
made using STATA version 8 (College Station, Texas). For
evaluating etiology code agreement across four reviewers,
we calculated the kappa statistic using the "kap" com-
mand in STATA where each observation is assumed to be
a subject, the number of raters is fixed (4 raters), and more
than two outcomes are possible (18 etiology codes). We
set a goal of >0.60 as desirable kappa value for designating
agreement as "substantial" or better according to the fol-







We assessed agreement on continuous measures (Adverse
Occurrence Severity Score, Degenerative Disease Severity
Score, and Spine Surgery Invasiveness Index) using intra-
class correlation methods using a SAS procedure (SAS
Institute, Cary, NC) [56]. We selected the intra-class corre-
lation coefficient (ICC) appropriate for a random sample
of reviewers, selected from a larger population, where
each reviewer rates each target. We set the significance




Between January 1, 2003 and July 1, 2003, 350 patients
had lumbar surgical procedures performed at the two par-
ticipating institutions. Among these, 210 consented for
enrollment in the study and 11 declined participation.
Patients were offered enrollment only in clinics staffed by
a research coordinator, and because of limited resources,
only the busiest spine clinics were staffed by research
coordinators. Target enrollment for the lumbar spine sur-
gery study is 1000 patients.
Ascertaining adverse occurrences
During the initial six months of this study, we recorded
172 adverse occurrences for patients undergoing lumbar
surgery for degenerative disease. Rigorous daily medical
record review identified 92.6% of the total number of
adverse occurrences and voluntary reports identified
38.5%; 31.1% of adverse occurrences were identified by
both voluntary reports and medical records. SurgeonsBMC Musculoskeletal Disorders 2006, 7:53 http://www.biomedcentral.com/1471-2474/7/53
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reported 18.3% of the total number of adverse occur-
rences ascertained; the inpatient team reported 23.1%,
and 6.1% of the total number of adverse occurrences were
reviewed or discussed in clinical care conferences, such as
morbidity and mortality conferences. Most adverse occur-
rences were identified only in medical records, such as
progress notes, laboratory reports, imaging reports, oper-
ation reports, and discharge summaries (61.5%). Sur-
geons were the sole source for 3.2% and inpatient team
members (nurse practitioners, residents, and fellows)
were the only source for 4.2%.
Categorizing adverse occurrences
After classifying some adverse occurrences during the ini-
tial training sessions, the four reviewers independently
coded the remaining 141 occurrences in 53 patients
(Tables 6 and 7). Agreement was substantial for four of
the 18 categories of error examined: technical error, fail-
ure in communication, systems failure, and no error
(Table 8). Agreement across all four reviewers was fair
when combined across all 18 error categories, and moder-
ate (using weighted kappa) for preventability and JCAHO
severity (Table 9). Numerical severity ratings using the
Adverse Occurrence Severity Score showed substantial
inter-rater agreement (ICC = 0.74, 95% CI = 0.68 – 0.79).
Measuring disease severity
Overall (mean) agreement for disease severity dimensions
was moderate across observers and substantial within
observers (Table 10). Inter-observer agreement was lowest
for herniation and instability and strongest for degenera-
tion. There was excellent agreement for the Degenerative
Disease Severity Score (ICC = 0.98, 95%CI = 0.96 – 0.99)
(Figure 3).
Measuring surgery invasiveness
Inter-researcher agreement was almost perfect for the
Invasiveness Index and for its six constituent elements
(Table 11). Surgeons completed the grid operative report
form as part of their medical record documentation in
only 53% of the cases. Agreement between the surgeons
and the researchers was very high on the forms completed
(Table 10) (Figure 4).
Discussion
Adverse occurrences are unwanted but common, often
carrying burdens of blame, guilt, or fear of sanctions
[57,58]. Terms such as complication, adverse event, and
medical error exacerbate the punitive atmosphere sur-
rounding undesirable outcomes, particularly when these
events are related to surgical procedures [59,60]. As a
result, despite a century-old tradition among surgeons to
focus intensely on complications in regular morbidity and
mortality conferences [61], discussions of adverse occur-
rences in the surgical literature are frequently dismissive
or defensive, leaving lessons buried under quality assur-
ance protections [62]. Sanitized or closed quality-of-care
discussions prevent systematic review of experience across
institutions or cumulative experience over time, restrict-
Graphical Grid for Coding Surgical Procedures Figure 2
Graphical Grid for Coding Surgical Procedures. 
Graphical grid used to code components of the surgical pro-
cedure. Each vertebral level is designated by a row. The col-
umns identify the possible surgical procedures performed at 
each level: posterior decompression, posterior fusion, poste-
rior instrumentation, anterior decompression, anterior 
fusion and anterior instrumentation.BMC Musculoskeletal Disorders 2006, 7:53 http://www.biomedcentral.com/1471-2474/7/53
Page 10 of 16
(page number not for citation purposes)
ing knowledge that may prevent future occurrences [63].
Mistakes get repeated. Patient safety suffers.
Approaches to measuring the safety of spine surgery are
not well-developed. We undertook preliminary evalua-
tions to help define a protocol to monitor adverse occur-
rences associated with spine surgery. We chose a design
engineering perspective to create a conceptual framework
with desirable components and specifications, including
multi-modal, standardized, comprehensive surveillance
of outcomes and detailed measurement of risk-adjust-
ment factors. Establishing multiple methods to track 176
adverse occurrences requires extensive resources and is
not practical for routine clinical surveillance. Identifying
the most common or most severe of these events may help
to select a smaller set of indicator events. Since many
adverse occurrences tended to cluster in cascades, under-
standing associations among occurrences may allow selec-
tion of a shorter list of critical surveillance items.
Quantifying disease severity on imaging studies and surgi-
cal invasiveness from medical records requires additional
extensive resources. While such a complex and bulky sys-
tem can be implemented in rigorous regulatory approval
studies of new devices or other well-funded trials, wide-
spread acceptance and application may require selecting
subsets of risk factors and adverse outcomes that directly
relate to specific patient safety concerns, or choosing those
parameters in this framework that can be ascertained reli-
ably from brief medical record reviews or administrative
data alone.
Comprehensive surveillance of all adverse occurrences is
difficult, if not impossible. Tracking surgical complica-
tions may be particularly troublesome because of issues
relating to responsibility and liability surrounding inva-
sive interventions. Although the true number of adverse
occurrences cannot be determined, our experience con-
firms that complementary surveillance methods provide
more complete assessment [64]. Our multi-modal
attempt for capturing adverse occurrences showed that
self-report by surgeons was not sufficient for identifying
most adverse occurrences, and neither was reliance on
voluntary reports by the spine team conducting daily ward
rounds. Contrary to experience reported for some settings
[30], in our study even designated professionals inte-
grated into the daily team rounds were not sufficient to
discern most adverse occurrences, perhaps because these
personnel were not consistently aware of intra-operative
occurrences, near-miss occurrences, or occurrences only
observed by consulting services. Also, surgical team mem-
bers may not have completely trusted the study goals dur-
ing the early study period reported here. Hopefully,
voluntary reporting can improve as team members
develop greater awareness of reporting methods, more
Table 7: Clustering among patients of adverse occurrences reviewed independently by all four reviewers.1
1 adverse occurrence in 22 patients
2 adverse occurrences in 9 patients
3 adverse occurrences in 7 patients
4 adverse occurrences in 6 patients
5 adverse occurrences in 5 patients
6 adverse occurrences in 1 patient
7 adverse occurrences in 1 patient
9 adverse occurrences in 2 patients
Total
141 adverse occurrences in 53 patients
1 Among the patients with an adverse occurrence, more than half (31/53) experienced multiple events. This clustering made cause, effect, and 
preventability judgments on individual events difficult.
Table 6: The sources for the pre-defined adverse occurrences 


















Escalation of care 7
Airway problems 3
Management List 5
Delay in surgery 3
Process of care issues 2
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certainty that prevention through learning is the sole
motive for surveillance, and in time, cultivate a culture of
safety that encourages openness.
Categorizing adverse occurrences is problematic. Review-
ers agreed in their discrimination of error from no error,
and they consistently identified errors related to technical,
communication, or systems failures. They were also able
to reliably assign severity ratings to adverse outcomes
using a scale that separated actual from potential effects.
Reviewers, however, had difficulty determining preventa-
bility of adverse occurrences and assessing severity using a
classification based on the JCAHO Sentinel Event Policy.
Adverse occurrences are products of complex patient and
treatment factors, often occurring in cascades where it is
difficult to isolate the causes and effects of individual
events. Reviewer agreement may be limited in part due to
lack of detailed information. Also, some consequences
may not be apparent at the time of hospital discharge,
when ratings were assigned. Agreement among reviewers
may improve with more experience, with provision of
more detailed narratives, or with development of simpler
coding scales.
Initial assessment of severity scoring for degenerative
changes in the lumbar spine is promising. Two orthopedic
surgeons showed good agreement in distinguishing
patients with mild degeneration from those with severe
degenerative changes. More work is needed to assess gen-
eralizability and to describe how different aspects of
degeneration may be related to presenting symptoms and
functional impairment. Such research may allow hierar-
chical ranking of broad diagnostic categories within lum-
bar spondylosis or permit weighting of different
components of degeneration.
Table 8: Etiology categories: Agreement among all four observers for 141 adverse occurrences coded by each reviewer.1
Etiology Code2 Category Kappa p-value
1 Error in diagnosis 0.52 0.0000
4 Failure to act on results 0.33 0.0000
5 Technical error3 0.66 0.0000
6 Error in preparation for operation 0.09 0.0064
7 Error in dose or method of use of a drug 0.21 0.0000
8 Avoidable delay in treatment 0.15 0.0000
9 Inappropriate care 0.06 0.0313
10 Failure to provide indicated prophylactic treatment 0.11 0.0007
11 Inadequate monitoring or follow-up 0.05 0.0738
12 Failure in communication3 0.80 0.0000
13 Equipment failure 0.33 0.0000
14 Other systems failure3 0.85 0.0000
15 Unclassified error 0.01 0.3453
16 Patient disease, expected risk (no error) 0.26 0.0000
17 Patient non-compliance (no error) 0.00 0.5206
18 Disease unrelated to spine surgery (no error) 0.22 0.0000
16, 17, or 18 No error (16, 17, or 18)3 0.61 0.0000
---- Combined (for all categories) 0.35 0.0000
1 Kappa statistic calculated using "kap" command in STATA Version 8 (College Station, TX). Each observation is assumed to be a subject, the 
number of raters is fixed (4 raters), and more than two outcomes are possible (18 etiology codes).
2 None of the 141 adverse occurrences were assigned etiology codes 2 or 3.
3 These categories show substantial or better agreement, with kappa values = 0.61
Degenerative Disease Severity Score Figure 3
Degenerative Disease Severity Score. The degenerative 
disease severity score assigned by two observers for 10 sam-
ple cases. Score by Observer 1 highly correlates with the 






































Ten sample cases, sorted by mean severity score
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Observer 2 Observer 2 repeat
Mean score for each case (line of equality) 
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Surgical procedures on the spine can be quantitatively
ranked for invasiveness. Although surgeons were only
able to provide this information routinely in just over half
the cases, when the information was provided, it was reli-
able. Compliance may improve with time, encourage-
ment, or proof of the value of such coding. Validation of
this ranking system by comparison to other indicators of
invasiveness, such as duration of surgery or blood loss,
may help better assess utility of the ranking system and
add meaning to the relative invasiveness of various proce-
dural elements.
Our study only included the busiest spine centers within
our network. This choice may have introduced bias. Surgi-
cal volume may influence both the frequency and the
reporting of adverse occurrences. Busier centers and sur-
geons may have lower rates of some occurrences and
higher rates of others. Incorporating additional tasks of
surveillance and reporting into routine care processes may
be more difficult in busy, high-volume settings. Some of
these concerns could be addressed by limiting surveil-
lance to only a select few adverse occurrences that are rou-
tinely recorded in operation reports and hospital
discharge summaries.
Our study placed emphasis on explicitly recording
absence of an adverse occurrence when none occurred.
Lack of occurrence of a particular complication with a par-
ticular procedure is important information. The efficiency
of surveillance of what occurred cannot be judged without
explicit data on what did not occur. No report does not
equal no occurrence. To be meaningful, adverse occur-
rence reports should specify what was monitored, how
often it occurred, and how often it did not occur.
We hope that sharing this protocol development will
stimulate discussion of these methodological issues and
push the field towards greater standardization in report-
ing and comparing adverse occurrence rates for devices,
techniques, and healthcare providers. Although our focus
is lumbar surgery for degenerative disease, the methods
described may be applicable also to surgery in other
Table 10: Disease Severity Scoring: Agreement between and within observers for 9 imaging disease characteristics for 10 patients. 
Each observer scored each case initially and then again approximately three weeks later.
Imaging Dimension Observer 1 vs 21 Observer 12 Observer 23
1. Degeneration 0.70 0.72 0.85
2. Height Loss 0.44 0.49 0.63
3. Osteophytes 0.47 0.53 0.67
4. Herniation 0.28 0.61 0.41
5. Stenosis 0.44 0.37 0.56
6. Listhesis 0.54 0.64 0.83
7. Instability 0.38 -0.02 1.00
8. Scoliosis Magnitude 0.51 1.00 0.58
9. Kyphosis Magnitude 0.42 0.62 0.62
Mean 0.45 0.58 0.67
1 Kappa value for inter-observer agreement between Observer 1 and Observer 2.
2 Kappa value for intra-observer agreement for Observer 1.
3 Kappa value for intra-observer agreement for Observer 2.
Table 9: Etiology, preventability, and the JCAHO severity ratings: Agreement between pairs of observers for 141 adverse occurrences 
coded by all four reviewers.
O-A1 O-JN2 O-SN3 A-JN4 A-SN5 JN-SN6 Mean7
Etiology, kappa 0.33 0.33 0.33 0.43 0.45 0.28 0.36
Preventability, weighted kappa 0.33 0.60 0.56 0.24 0.43 0.49 0.44
JCAHO Severity, weighted kappa 0.25 0.57 0.34 0.26 0.21 0.31 0.33
1Agreement between the orthopedic surgeon reviewer(O) and the anesthesiologist(A).
2Agreement between the orthopedic surgeon reviewer(O) and the junior neurosurgeon(JN).
3Agreement between the orthopedic surgeon reviewer(O) and the senior neurosurgeon(SN).
4Agreement between the anesthesiologist(A) and the junior neurosurgeon(A).
5Agreement between the anesthesiologist(A) and the senior neurosurgeon(SN).
6Agreement between the junior neurosurgeon(JN) and the senior neurosurgeon(SN).
7 Mean for all six pairs of reviewers.BMC Musculoskeletal Disorders 2006, 7:53 http://www.biomedcentral.com/1471-2474/7/53
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Table 11: Surgery Invasiveness Scoring: Inter-rater agreement for procedure invasiveness measurements for 50 consecutive 
operations coded by the treating surgeon and two researchers.
Procedure Characteristic Researchers1 Surgeons2
ICC (95%CI) ICC (95%CI)
Invasiveness Index 0.998 (0.997 to 0.999) 0.995 (0.993 to 0.997)
Anterior decompression 0.995 (0.992 to 0.997) 0.872 (0.814 to 0.920)
Anterior fusion 0.992 (0.988 to 0.995) 0.912 (0.872 to 0.945)
Anterior instrumentation 0.994 (0.991 to 0.996) 0.923 (0.887 to 0.951)
Posterior decompression 1.000 0.992 (0.989 to 0.995)
Posterior fusion 0.999 (0.999 to 1.000) 1.000
Posterior instrumentation 1.000 0.996 (0.994 to 0.997)
1Intraclass correlation coefficients for agreement between the two researchers: surgeon-investigator and a trained research assistant.
2Intraclass correlation coefficients for agreement between the treating surgeon and the researchers.
Spine Surgery Invasiveness Index Figure 4
Spine Surgery Invasiveness Index. Spine Surgery Invasiveness Index assigned by the treating surgeon and two researchers 
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regions of the spine. The analytic approach described may
also have relevance for efficacy level evaluation of current
and new procedures. Individual hospital and provider
level analyses may be useful for effectiveness research and
quality improvement.
Conclusion
Approach to measuring the safety of spine surgery can be
standardized. Scales for rating the impact of adverse
occurrences, severity of lumbar spine degeneration, and
invasiveness of spine surgery have acceptable reproduci-
bility. Reviewers frequently disagree on causes of adverse
occurrences.
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